A detailed history of Perkins Capital Management Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Perkins Capital Management Inc holds 21,000 shares of LUNG stock, worth $31,290. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,000
Previous 10,000 110.0%
Holding current value
$31,290
Previous $25,000 36.0%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$1.51 - $3.78 $16,610 - $41,580
11,000 Added 110.0%
21,000 $34,000
Q2 2025

Aug 07, 2025

BUY
$2.57 - $6.87 $25,700 - $68,700
10,000 New
10,000 $25,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $55.5M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.